Citation: A. Vanelsas et al., BLOCKADE OF CTLA-4 COMBINED WITH A GM-CSF VACCINE CURES MICE FROM THEHIGHLY TUMORIGENIC, POORLY IMMUNOGENIC MELANOMA B16-BL6, AND INDUCES SKIN DEPIGMENTATION, The FASEB journal, 12(5), 1998, pp. 5258-5258
Authors:
VANELSAS A
AARNOUDSE C
VANDERMINNE CE
VANDERSPEK CW
BROUWENSTIJN N
OSANTO S
SCHRIER PI
Citation: A. Vanelsas et al., TRANSFECTION OF IL-2 AUGMENTS CTL RESPONSE TO HUMAN-MELANOMA CELLS IN-VITRO - IMMUNOLOGICAL CHARACTERIZATION OF A MELANOMA VACCINE, Journal of immunotherapy with emphasis on tumor immunology, 20(5), 1997, pp. 343-353
Authors:
JANSEN B
SCHLAGBAUERWADL H
EICHLER HG
WOLFF K
VANELSAS A
SCHRIER PI
PEHAMBERGER H
Citation: B. Jansen et al., ACTIVATED N-RAS CONTRIBUTES TO THE CHEMORESISTANCE OF HUMAN-MELANOMA IN SEVERE COMBINED IMMUNODEFICIENCY (SCID) MICE BY BLOCKING APOPTOSIS, Cancer research, 57(3), 1997, pp. 362-365
Authors:
WADL H
VANELSAS A
SCHRIER PI
WOLFF K
EICHLER KG
PEHAMBERGER H
JANSEN B
Citation: H. Wadl et al., HIGH C-MYC EXPRESSION POSITIVELY CORRELATES WITH METASTATIC POTENTIALOF HUMAN-MELANOMA IN SCID MICE, Journal of investigative dermatology, 107(3), 1996, pp. 146-146
Authors:
JANSEN B
INOUE SA
WADL H
EICHLER HG
WOLFF K
VANELSAS A
SCHRIER PI
PEHAMBERGER H
Citation: B. Jansen et al., N-RAS ONCOGENE EXPRESSION CHANGES THE GROWTH-CHARACTERISTICS OF HUMAN-MELANOMA IN 2 INDEPENDENT SCID-HU MOUSE MODELS, International journal of cancer, 67(6), 1996, pp. 821-825
Authors:
VANELSAS A
VANDERBURG SH
VANDERMINNE CE
BORGHI M
MOURER JS
MELIEF CJM
SCHRIER PI
Citation: A. Vanelsas et al., PEPTIDE-PULSED DENDRITIC CELLS INDUCE TUMORICIDAL CYTOTOXIC T-LYMPHOCYTES FROM HEALTHY DONORS AGAINST STABLY HLA-A-ASTERISK-0201-BINDING PEPTIDES FROM THE MELAN-A MART-1 SELF ANTIGEN/, European Journal of Immunology, 26(8), 1996, pp. 1683-1689
Authors:
VANELSAS A
ZERP SF
VANDERFLIER S
KRUSE KM
AARNOUDSE C
HAYWARD NK
RUITER DJ
SCHRIER PI
Citation: A. Vanelsas et al., RELEVANCE OF ULTRAVIOLET-INDUCED N-RAS ONCOGENE POINT MUTATIONS IN DEVELOPMENT OF PRIMARY HUMAN CUTANEOUS MELANOMA, The American journal of pathology, 149(3), 1996, pp. 883-893
Authors:
VANELSAS A
NIJMAN H
VANDERMINNE C
MOURER J
MELIEF C
SCHRIER PI
Citation: A. Vanelsas et al., A WILD-TYPE AND A MUTANT P21RAS PEPTIDE ELICIT CTL RESPONSES IN THE HUMAN, Journal of cellular biochemistry, 1995, pp. 180-180
Authors:
INOUE SA
WADL H
JANSEN B
VANELSAS A
SCHRIER PJ
EICHLER HG
WOLFF K
PEHAMBERGER H
Citation: Sa. Inoue et al., N-RAS ONCOGENE EXPRESSION CHANGES THE GROWTH-CHARACTERISTICS OF HUMAN-MELANOMA IN 2 INDEPENDENT SCID-HU MOUSE MODELS, Journal of investigative dermatology, 105(3), 1995, pp. 454-454
Authors:
JANSEN B
WADL H
VANELSAS A
SCHRIER PI
EICHLER HG
WOLFF K
PEHAMBERGER H
Citation: B. Jansen et al., N-RAS ONCOGENE EXPRESSION CHANGES IN-VITRO AND IN-VIVO GROWTH-CHARACTERISTICS OF HUMAN-MELANOMA, Journal of investigative dermatology, 104(4), 1995, pp. 673-673
Authors:
VISSEREN MJW
VANELSAS A
VANDERVOORT EIH
RESSING ME
KAST WM
SCHRIER PI
MELIEF CJM
Citation: Mjw. Visseren et al., CTL SPECIFIC FOR THE TYROSINASE AUTOANTIGEN CAN BE INDUCED FROM HEALTHY DONOR BLOOD TO LYSE MELANOMA-CELLS, The Journal of immunology, 154(8), 1995, pp. 3991-3998
Authors:
VANELSAS A
NIJMAN HW
VANDERMINNE CE
MOURER JS
KAST WM
MELIEF CJM
SCHRIER PI
Citation: A. Vanelsas et al., INDUCTION AND CHARACTERIZATION OF CYTOTOXIC T-LYMPHOCYTES RECOGNIZINGA MUTATED P21RAS PEPTIDE PRESENTED BY HLA-A-ASTERISK-0201, International journal of cancer, 61(3), 1995, pp. 389-396
Authors:
VANELSAS A
VANDEURSEN E
WIELDERS R
VANDENBERGBAKKER CAM
SCHRIER PI
Citation: A. Vanelsas et al., RAS ONCOGENE ACTIVATION DOES NOT INDUCE SENSITIVITY TO NATURAL-KILLER-CELL - MEDIATED LYSIS IN HUMAN-MELANOMA, Journal of investigative dermatology, 103(5), 1994, pp. 190000117-190000121